DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Hochhaus A, Masszi T, Giles FJ. et al.
Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study.
Leukemia 2017;
31 (07) 1525-1531
We do not assume any responsibility for the contents of the web pages of other providers.